| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 969,935 | 1,037,162 | 951,160 | 1,151,062 | | Cost of Revenue | 836,449 | 889,317 | 819,389 | 996,448 | | | Gross Profit | 133,486 | 147,845 | 131,771 | 154,614 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 117,623 | 117,518 | 139,690 | 137,926 | | Non Recurring | 3,994 | 8,477 |
-
| 86,485 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,869 | 21,850 | (7,919) | (69,797) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (265) | 148 | (128) | (5,878) | | Earnings Before Interest And Taxes | 11,604 | 21,998 | (8,047) | (75,675) | | Interest Expense | 2,333 | 1,989 | 2,099 | 3,730 | | Income Before Tax | 9,271 | 20,009 | (10,146) | (79,405) | | Income Tax Expense | 1,999 | 7,116 | (3,349) | 3,278 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,272 | 12,893 | (6,797) | (82,683) | | | Non-recurring Events | | Discontinued Operations |
-
| 2,801 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,272 | 15,694 | (6,797) | (82,683) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,272 | $15,694 | ($6,797) | ($82,683) |
|
0.51% Nasdaq 
Income Statement
